Introduction
Chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) is a B-cell clonal lymphoproliferative disorder characterized by the accumulation of small lymphocytes in the peripheral blood, bone marrow and lymph nodes deriving from the transformation of a CD5 þ B-cell. Recurrent molecular cytogenetic abnormalities may identify specific disease subtypes in CLL/SLL. 1, 2 The most frequent aberrations include 3 13q14 deletion (40-50% incidence); 11q22-23 deletion (10-20% incidence); total or partial trisomy 12 (10-15% incidence); and 17p13 deletion (2-7% incidence). The 17p/p53 deletion and the 11q-deletion involving the ATM gene were associated with an unfavorable outcome. 4, 5 Evidence was also provided that 6q deletion may be found in a subset of SLL 6 and CLL with hyperleukocytosis and intermediate outcome 7, 8 and that 14q32 translocations involving the immunoglobulin heavy (IgH) chain gene may be associated with unfavorable prognosis. 9, 10 A characteristic histopathologic feature of SLL/CLL is represented by 'proliferation centers' (PCs), which consist of regularly distributed pale areas without a mantle with numerous prolymphocytes and paraimmunoblasts, resulting in a pseudofollicular pattern. 11 Unlike reactive germinal centers, the PCs are CD10-, Bcl6-, IRF4 þ and bcl2 þ , 12, 13 and contain large Ki-67 þ cells, admixed to typical B-CLL cells. They are visible on bone marrow and lymph node sections, and probably represent the sites where the T-dependent immune response to an unknown antigen promotes the selection and the clonal expansion of B-cells. 14 Although the size of PCs and the amount of paraimmunoblasts in lymph node sections did not show a correlation with clinical course, 15, 16 the presence of more extensive PCs in follow-up biopsies compared with diagnostic biopsies has been reported. 17 Interestingly, a recent study suggested that an association may exist between the expanded and highly active PCs and an aggressive variant of CLL. 18 Recently, techniques were developed that allow for the application of fluorescence in situ hybridization (FISH) on paraffin-embedded fixed tissues. 19, 20 The preparation of tissue microarray (TMA) for FISH analysis 21 made this technique a potentially ideal method for the screening of large number of cases in a single hybridization experiment.
AsFto the best of our knowledgeFonly few data are available on the cytogenetic profile of lymph nodes in CLL/SLL and the presence of chromosome lesions in correlation with the extension of PCs has never been previously tested, we designed the present study aiming to:
(i) analyze the sensitivity and reproducibility of FISH on paraffin-embedded fixed tissues arranged on TMA from 183 consecutive lymph node biopsies corresponding to histologically ascertained CLL/SLL, (ii) estimate the frequency of chromosome lesions on lymph node samples and (iii) analyze the possible correlation of specific chromosome lesions and the extension of PCs, and how these features may impact on clinical outcome.
Patients and methods

Patients
A total of 183 consecutive patients with CLL/SLL diagnosed according to NCI criteria, 22 submitted to excisional lymph node biopsy for diagnostic purposes, were included in this study. All the patients had a clonal B-cell population with CD5 þ , CD19 þ , CD23 þ and surface kappa/lambda light chain restriction.
Lymph node biopsy in these patients was performed in the presence of progressive disease 23 requiring treatment, with adenopathies X3 cm. In all, 49% of these patients were untreated, 51% had received 1-3 lines of treatment (median 2 lines).
These patients were referred for histological diagnosis at the Hemolymphopathology Service of S.Orsola-Malpighi Hospital, Bologna University, Bologna, Italy between 2002 and 2008. The only selection criterion was represented by the availability of sufficient amount of paraffin-embedded tissue.
Histopathologic studies
Each biopsy had been fixed in formalin. Hematoxylin-eosin, Giemsa, Gomori and immunohistochemical stains performed at the time of diagnosis were always available. All cases were reviewed by three observers (SP, CA and ES). CLL diagnosis was confirmed in all instances based on cell morphology and phenotype. 11 The latter resulted: CD3 À , CD20 þ (the staining ranging from weak in the small B-cell component to moderate in PCs), CD79a
À and BCL2 þ . Details of the antibodies and techniques applied are reported in Table 1 .
The cases were classified into two categories according to the previously reported criteria 16 : 'PCs-rich' and 'typical'. The former included those cases with confluent PCs whereas the latter showed scattered, small, ill-defined PCs in a monotonous background of small, relatively round lymphocytes (Figure 1) . No histological shift to DLBCL (Diffuse Large B-Cell Lymphoma) was recorded.
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Tissue microarrays
A slide stained with Giemsa was prepared from each paraffin block, and representative tumor regions including scattered or confluent PCs were morphologically identified and marked on every slide. Tissue cylinders with a diameter of 1.0 mm were punched from the marked areas of all blocks and brought into a recipient paraffin block using a precision instrument, as previously described. 24 The biopsies were arranged in seven TMAs, each containing material from 32-46 cases. In addition, a number of normal samples (spleen, thymus, tonsil or lymph node) were included in all TMAs as internal controls. Different copies of each TMA were prepared to allow immunohistochemistry and fluorescence in-situ hybridization FISH with a 5-probe panel (see below).
Immunohistochemistry
The 4-mm-thick sections were cut from each recipient block and tested with anti-ZAP70 and anti-Ki-67. Technical details are provided in Table 1 .
The immunohistochemical results were independently scored by three pathologists (SP, CA and ES) as follows: þ , 475% positive cells; þ /À, 50-75% positive cells; À/ þ , 25-50% positive cells; rare, 10-25% positive cells; and À, o10% Fluorescence in situ hybridization Preparation of the slides and hybridization. The 4-mmthick sections were preferred for FISH assays, as recommended by Ventura et al. 19 to limit the number of nuclei truncation during sectioning and consequent loss of probe signals. Each TMA was submitted to hybridization using the following 5-probe panel in dual-colour hybridization tests using a chromosome 10 centromeric probe as internal control in each experiment: Spectrum orange LSI ATM DNA probe to the band 11q22.3; Spectrum orange LSI D13S25 DNA probe (band 13q14.3); Spectrum orange LSI p53 probe to the band 17p13.1; Spectrum orange CEP 12 alpha satellite probe to the centromere band of chromosome 12 and Spectrum green CEP 10 alpha satellite probe to the centromere of chromosome 10; and LSI IGH Dual Color, break-apart rearrangement probe (14q32/IgH gene breakpoint). These probes were purchased by Vysis Co (Downers Grove, IL, USA), distributed by Abbott Co (Rome, Italy). As previously suggested, 25 the slides were submitted to a dewaxing step consisting of heating at 55 1C for 10 or more minutes followed by washing in xilene for 10 min Â 3 times at room temperature. Subsequently, the slides were dehydrated twice in ethanol 100% for 5 min. The demasking step was performed combining chemical treatment and high temperature: thus the slides were immersed in a 1 mmol ethylendiaminetetraacetic acid solution in pressure cooker at boiling point temperature for 4 min. To reduce background noise and enhance signal intensity, the slides were bathed in a proteolytic solution containing chloride acid and pepsin for 14 min at 37 1C. Finally, the slides were fixed in 10% formalin solution, re-hydratated in an inverse ethanol alcohol series (100, 85 and 70%) and dried at room temperature. Each probe (10 ml) was added to each slide and covered with a coverslip. Rubber cement was used to seal the edges, and the slides were placed in the co-denaturation/hybridization device (ThermoBrite, Abbott Co). FISH on tissue microarrays in CLL M Ciccone et al DNA denaturation was obtained at a melting temperature of 80 1C for 22 min followed by overnight hybridization with each probe by incubation at 38 1C. Post-hybridization washes included baths at 75 1C in 0.4 Â SSC/0.3% NP-40 (Vysis Co) for 2 min, and at a room temperature in 2 Â SSC/0.1% NP-40 for 1 min. A 10 ml of DAPI II counterstain (Vysis Co) was applied to the target area and a coverslip was added.
FISH signal screening. Evaluation of FISH results was performed on a fluorescence-equipped microscope (Nikon Italia, Milan, Italy) with a charge-coupled black and white camera, and appropriate hardware and software. The results of FISH labeling were interpreted and scored by one investigator (MC) unaware of the histological data. Depending on the amount of cells for each core section, at least 100 and usually 200-300 nuclei were manually scored. To ensure accuracy of the analysis, scoring was performed on almost the entire core section, and both cores were screened for each case. Signal screening was performed in those areas without excessive overlapping, avoiding areas where nuclei borders were not clearly shaped. For the break-apart probe, a nucleus with a fusion signal (normal signal), one red and one green signal (split signal), was scored as translocated. The presence of one fusion signal and one single-color signal (either red or green) was considered as indicative of deletion of part of the Ig gene, a phenomenon reflecting physiologic rearrangement of the IgH gene. 26 Cut-off for positivity. To establish the cutoff, we used 10 cases of reactive tonsil, spleen and thymus tissues arranged in the five TMAs plus two reactive lymph nodes on two separate slides. The cutoff point for positivity was set at 43% for probes detecting deletions, at 4.1% for probes detecting trisomy 12 and at 6.1% for the 14q32/IgH translocation probe, corresponding to the mean false-positive values obtained on the 12 control-cases plus 3 s.d.'s 19 A case was classified as carrier of deletion or trisomy provided that a concomitant normal hybridization pattern was observed with the chromosome-10-centromeric probe. As previously described by Meiner et al. 27 amplification was defined as the presence of tumor cell nuclei with three or more signals exceeding the mean plus 3 s.d. of tri-/polysome nuclei in the reference cases.
To further verify the specificity and accuracy of our method, FISH was performed on tissue sections of 18 cases of CLL/SLL with known cytogenetic lesions, detected by FISH on cell suspensions obtained from the same lymph node biopsy.
Immunoglobulin heavy chain variable region (IGHV) mutational status
IGHV mutations were studied in 67 patients with a complete set of clinicobiologic data for whom sufficient material was available. Genomic DNA was isolated from paraffin-embedded lymph nodes using QIAmp DNA mini kit (Qiagen, Milan, Italy), and subjected to amplification of the VDJ (variable/diversity/ joining) gene rearrangements by polymerase reaction (PCR). In particular, IGHV rearrangements were amplified with familyspecific primers hybridizing to sequences in the framework region 1 or framework region 2 in conjunction with JH primers, in separate reactions for each VH family. 28 The PCR products, after ethidium bromide stained agarose gel electrophoresis, were spin column purified (Promega, Milan, Italy) and directly sequenced. IGHV sequences were aligned to the international ImMunoGeneTics database (IGMT http://imgt.cines.fr; initiator and coordinator: Marie-Paule Lefranc, Montpellier, France) using the IgBLAST software (http://www.ncbi.nlm.nih.gov/ igblast/). IGHV sequences were considered mutated if deviation from the corresponding germline gene was 42%.
Statistical analysis
Quantitative variables were reported as mean values with s.d.'s and were compared using Mann-Whiney test. The Fisher exact test was used for categorical variables. All tests were two-sided. The overall survival was calculated as the interval between biopsy and the last follow-up. Survival curves were compared using the log-rank test. A P-value o0.05 was used as a criterion for statistical significance. Proportional hazards regression analysis was used to identify the most significant independent prognostic variables on overall survival. Statistical analyses were obtained using Stata software release 8.0 (Stata Corporation, College Station, TX, USA).
Results
FISH studies
Efficiency of hybridization. Hybridization with each single probe was successful in 61.7-80.3% of the cases (Figure 2 ), as shown in Table 2 Table 2 ) were accounted for by the absence of adequate number of cells on TMA corresponding cores in 12.5-26.2% of the cases; inefficient hybridization and overlapping nuclei precluded accurate signal screening in 7.1-13.2% of the cases.
In 18 cases with known cytogenetic aberrations on conventional cell suspensions obtained from fresh lymph node biopsy, FISH analysis on paraffin-embedded tissues confirmed the presence of 11q-(8/18 cases), þ 12 (5/18 cases), 13q-(7/18 cases), 14q32/IgH translocation (6/18 cases) and of 17p-(6/18 cases), in the absence of false-positive results.
Incidence of chromosome lesions. There was no significant difference in the incidence of 13q-, þ 12, 11q-and 14q32 translocations in untreated vs pretreated patients, whereas 17p-occurred more frequently in treated patients as compared with untreated patients (26% and 6.5% of the cases, respectively).
A total of 79 out of 101 patients successfully analyzed with the 5-probe panel (78.2%) showed at least one chromosomal aberration, as shown in Table 3 . Using a cytogenetic classification assigning every patient to a single category according to the hierarchy 17p-411q-414q32 4 þ 12 413q-, 3,9 the 11q deletion was the most frequent cytogenetic anomaly accounting for 20% of the cases, followed by 17p-(17%), 14q32/IgH translocation (16%), 13q-(15.8%) and trisomy 12 (11%).
Histopathologic subtypes and their association with biologic features
A total of 108/183 cases (59.1%) with scattered PCs were assigned to the typical subtype. A total of 75/183 cases (40.9%) were assigned to the PCs-rich subtype, owing to the presence of confluent PCs. In 35 cases (19.1%) paraimmunoblasts represented the predominant cell population within the PCs, in 14 cases (7.6%) the vast majority of cells were prolymphocytes and in 26 cases (31.3%) a mixture of paraimmunoblasts and prolymphocytes was seen. Notably, none of the cases with predominant paraimmunoblastic cell population within confulent PCs had the clinical characteristics of Richter's syndrome.
When considering those cases with successful hybridization with each single probe, 17p-, þ 12 and 14q32/IgH translocation were more frequently encountered in the PCs-rich subtype than in the typical subtype (20/60 cases vs 3/87 for 17p-, Po0.001; 15/52 vs 11/81 for þ 12, P ¼ 0.030; and 22/54 vs 20/82 for 14q32 translocations, P ¼ 0.043).
Ki67 was positive in 430% of the cells in 27/164 cases successfully tested: 4/95 Ki-67 þ cases belonged to the 'typical' Table 2 Efficiency of FISH studies on samples arranged on TMA (Table 4 ). These 101 patients were representative of the entire series in terms of incidence of confluent PCs (37% vs 40.9% in the total series, P ¼ NS) and of scattered PCs (64% vs 59.1% in the total series, P ¼ NS). IGHV usage in correlation with mutational status in 67 cases is shown in Figure 3 . Rearranged IGHV families recurrently involved were as follows: IGHV1-69: 19.4%; IGHV3-30: 11.9%; IGHV3-7: 7.4%; IGHV3-23, IGHV3-48, IGHV4-34 and IGHV4-39: 6% each. Others IGHV families were involved in 45% of the cases.
As shown in Table 4 , 17p-, 14q32/IgH translocations, þ 12 and 'unfavorable' FISH abnormalities (that is, 11q-and 17p-) were more frequently encountered in the PCs-rich subtype than in the typical subtype. Likewise, Ki-67 positivity in 430% of cells, being pretreated at time of biopsy and longer interval between diagnosis and biopsy, were associated with the PCs-rich subtype, whereas no significant association was noted between ZAP-70 þ , IGHV mutational status and histological subtypes. Abbreviations: FISH, fluorescence in situ hybridization; IGHV, immunoglobulin heavy chain variable region; NS, not significant; PC, proliferation center.
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As shown in Table 5 , the median survival from the time of tissue biopsy for PCs-rich and typical subtypes in 86 patients for whom clinical data could be obtained was 11 and 64 months, respectively (P ¼ 0.00001) (Figure 4a ). Other variables that influenced negatively the survival in our series were unfavorable cytogenetic abnormalities (17p-and/or 11q-), Ki-67430% and being pretreated at the time of biopsy.
Survival in 47 patients, not included in the multiparameter analysis due to incomplete FISH data, was shorter in 24 PC-rich cases than in 23 typical cases (P ¼ 0.04) (Figure 4b) .
A Cox proportional-hazards analysis showed that only PCs-rich pattern retained predictive value of poor outcome (HR 2.74, 95% CI 1.16-6.51, P ¼ 0.022), while the presence of high-risk cytogenetic abnormalities, treatment status and Ki67430% did not have an independent impact on survival.
Discussion
As tissue biopsy is not mandatory for the diagnosis of CLL, few studies addressed the significance of histological findings 15, 16 and the incidence of chromosomal aberrations at the tissue level in this setting. 29, 30 The TMA technology offers the possibility to analyze simultaneously a consistent number of cases thus reducing costs and experimental variability. 21, 24 To the best of our knowledge, the present study represents the most extensive analysis conducted on biopsies of patients affected by CLL/SLL. A preliminary methodological problem with FISH on histological preparations is represented by the accuracy of signal screening, in relation to the thickness of the section. On the one hand, a thick section may influence the cutoff point because overlapping nuclei would increase both the false-positive rate for trisomies and the falsenegative rate for deletions; on the other hand, a thin section would cause major truncation artefacts, rendering more probable the loss of one or more signals, yielding false deletions and falsely normal results in the presence of trisomy. To ensure the accuracy of FISH data in our study, we elected (i) to adopt in all sections the same 4-mm thickness, which proved to be the most reasonable compromise in our experience, in line with previous studies, 19 (ii) to calculate the cutoff for positivity in a large number of controls (12 cases) with various reactive conditions, (iii) to use an internal control probe in each hybridization to ensure accuracy of signal screening, (iv) to use the same criteria for the evaluation of all cases, selecting the best area of the core section (that is, minimal nuclei overlapping and truncation) for signal screening and (v) to confirm the reproducibility of our method by comparing the results on tissue samples and on fresh cell suspensions in 18 patients with known cytogenetic aberrations.
In this study, hybridization efficiency was very good, with a 55.1% overall success rate using a 5-probe panel in an unselected series of 183 cases. 30 Excluding those cases in which failure was a consequence of lack of tissue, assessable results were obtained in 86.8 to 92.8% of the cases with each single probe (Table 1) A second methodological consideration should be raised concerning patient selection for this study. As in previous studies, 23 patients with progressive disease and clinically relevant adenopathy were included in our analysis. Therefore, the patient population was not representative of the entire CLL population seen at the referring centers during the study period, and FISH analysis was performed in biopsies taken in different phases of the history of the disease.
In line with these considerations, the IGHV usage in our cases showed frequent V1-69 gene involvement, mostly in the unmutated configuration, a relatively low VH4-34, frequently found in mutated CLL, 31 and very low incidence of other VH subtypes normally associated with indolent CLL or monoclonal B-cell lymphocytosis. 31 An unexpectedly high 12% incidence of V3-30 involvement was seen in our series. Unlike previous reports, describing V3-30 usage in association with mutated CLL running an indolent course, 32,33 7/8 cases using V3-30 genes in this series lacked IGHV somatic mutations (Figure 3) , suggesting that the mutational status might be an important determinant of outcome within specific IGHV families.
The 78.2% overall incidence of chromosome lesions in our study using a 5-probe panel is in line with previous analyses performed on PB samples obtained from untreated and pretreated patients. 3, 8 Caraway et al. 30 found abnormal FISH signal patterns in 81% of CLL/SLL cases on fine-needle aspirates, and Flanagan et al. 29 described at least one cytogenetic aberration in all 18 patients analyzed on lymph node biopsy.
Interestingly, while confirming that the occurrence of 17p-was more common in relapsed CLL, 34 other aberrations were found in our series to occur at a similar incidence in untreated and in treated patients. 11q deletion is usually associated with a disease characterized by marked lymphadenopathy. 5 As the incidence of 11q-may be higher in patients with therapy-demanding disease independent by previous treatments, 35 the relatively high incidence of 11q-in our series FISH on tissue microarrays in CLL M Ciccone et al (24.7%) may be accounted for by inclusion in this study of patients with clinically significant adenopathy. A previously unreported finding was represented by a high incidence (30.8%) of 14q32/IgH translocations both in treated and in untreated patients. Three possible explanations may account for this observation: i) 14q32 translocation may appear more frequently at the tissue level than in the PB, as previously suggested for trisomy 12. 36 It is worth noting that cores for microarray construction were obtained from those areas with PC in the original lymph node section, and that PC may be viewed as a genetically unstable proliferation compartment releasing small lymphocytes in the accumulation compartment and in the PB 14 ; ii) 14q32 translocation may be associated with adenopathy and active disease requiring treatment, as suggested in two recent analyses 9, 10 ; and iii) 14q32 translocation may represent in some of our cases a secondary anomaly acquired late during the course of the disease. Indeed, karyotype instability was detected in a fraction of CLL, [37] [38] [39] and 14q32/ IgH translocation may represent a late event in the progression of lymphoid neoplasias. 40 Interestingly, recent analyses on a limited number of CLL patients reported a 17-21% incidence for these translocations in lymph node samples, 29, 41 and 18 independent lymph node biopsies submitted to FISH analysis on isolated cell suspension in this study gave a 33% incidence for this aberration.
Furthermore, we detected five cases with a minority of cells showing IgH amplification as additional aberration, a finding previously unreported in molecular cytogenetic studies conducted on PB samples. 42, 43 Interestingly, the 14q32/IgH region was recently found to be involved in the genesis of complex rearrangements, referred to as 'complicons', including multiple rearrangements and gene amplification. 44 Further study is required to clarify how and at what extent gains of chromosome material surrounding the Ig genes at 14q32 could contribute to the pathogenesis of B-derived lymphoproliferative diseases.
To our knowledge, this is the first study analyzing the correlation between the histological features and the cytogenetic profiles in CLL.
The frequency of PCs-rich CLL in our series was 40.9%, and 14q32/IgH translocations, þ 12 and 17p-, were significantly associated with the PCs-rich group.
Unfavorable cytogenetic features, such as 11q-/17p-, were more frequently encountered in the PCs-rich group than in the typical group. The presence of prominent PCs, which was associated with ki-67 þ in our analysis, is thought to be an index of B-cell proliferation capability, which increases the risk that DNA replication errors could happen, thus predisposing the cell to the acquisition of sequential genetic damage. Likewise, ATM and p53 gene deletions impair the checkpoint cell machinery and render the cell more fragile to antigenic stimuli encountered at PCs level. These considerations may provide a biological basis to explain the strong unfavorable prognostic significance of confluent PC in SLL/CLL that was found in our study. Interestingly, Gine et al. 18 recently described a new histological category, that is, 'accelerated' CLL, including 23 out of 78 (29.4%) cases with enlarged and confluent PCs, with 42.4 mitosis per PCs and 430% Ki-67 per PCs. This histological subset of CLL was associated with adverse biological features and inferior survival. Our data support and reinforce this view, in that they show that confluent PCs are associated with adverse cytogenetics and represent the strongest prognostic factor.
In conclusion, we have demonstrated that FISH on TMA is a convenient tool for the detection of cytogenetic aberrations in CLL/SLL. The association of PCs-rich pattern with unfavorable cytogenetics and short survival may support the pathogenetic role of 'proliferation center' in CLL. As the patients included in this analysis represented an unselected cohort of CLL/SLL undergoing biopsy due to clinically significant adenopathy, we found a high incidence of adverse biologic features, that is, unmutated IGHV configuration, ZAP70 þ , and 'high risk' cytogenetics. While the latter features did not have prognostic predictivity at multivariate analysis in this clinically aggressive population, our study demonstrated that the histopathological pattern defined by the presence of confluent PCs may represent an important feature for risk assessment in this subset of patients. This finding is important when considering that increasing awareness of the possible evolution into Richter's syndrome is prompting clinicians to perform lymph node biopsy more often than in the past, 45 and that the therapeutic armamentarium in clinically aggressive CLL may include intensive chemoimmunotherapy 46 and allogeneic bone marrow transplantation from HLA-identical siblings and well-matched unrelated donors. 47, 48 
